Sedating Antidepressant Improves Driving Safety in Patients With Major Depressive Disorder

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2003
This concurrent, two-part study will: I) Using overnight sleep recordings, evaluate the short- and long-term sleep-promoting effects of the antidepressant mirtazapine (Remeron) in patients who have been prescribed this medication for major depressive disorder and sleep disruption. II) Investigate the psychomotor performance of depressed patients using driving simulation testing before and during treatment with mitrazapine.
Epistemonikos ID: be20a7c2227c50adc35ca63629f397fd1fa95ce9
First added on: May 04, 2024